Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Jasper Therapeutics Inc
JSPRCurrent price
22.1 USD
-0.71 USD (-3.11%)
Last closed
22.8 USD
Company
jaspertherapeutics.com
ISIN
US4718711033
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
370 533 024 USD
Yield for 12 month
+284.41 %
1Y
3Y
5Y
10Y
15Y
JSPR
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and conditioning regimens for stem cell transplantation. In addition, it is also developing stem cell transplants for rare diseases such as sickle cell disease, fanconi anemia, chronic granulomatous diseases, and GATA2 MDS, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California. Address: 2200 Bridge Pkwy, Redwood City, CA, United States, 94065
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
73.29 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+13 511 000 USD
Current Quarter
–
Last Quarter
–
Current Year
-1 108 000 USD
Last Year
-1 310 000 USD
Current Quarter
–
Last Quarter
-299 000 USD
Key Figures JSPR
1 year
3 years
5 years
10 years
EBITDA
-67 006 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-35.78 %
PEG Ratio
–
Return On Equity TTM
-59.32 %
Wall Street Target Price
73.29 USD
Revenue TTM
–
Book Value
7.03 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-5.1 USD
Diluted Eps TTM
-5.1 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics JSPR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History JSPR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
04.01.2024
Dividend Date
–
Stock Valuation JSPR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.4159
Price Book MRQ
3.6939
Financials JSPR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators JSPR
For 52 weeks
4 USD
31.01 USD
50 Day MA
19.93 USD
Shares Short Prior Month
1 494 379
200 Day MA
21.38 USD
Short Ratio
5.51
Shares Short
1 809 935
Short Percent
12.14 %
BeatStart